Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus

We examined if urinary angiotensinogen (uAOG), a marker of intrarenal renin‐angiotensin system activity, antedates stage 3 chronic kidney disease (CKD) using samples from participants in the Diabetes Control and Complications Trial (DCCT) and later in the Epidemiology of Diabetes Intervention and Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ba Aqeel, Sheeba, Ye, Minghao, Wysocki, Jan, Sanchez, Alejandro, Khattab, Ahmed, Lores, Enrique, Rademaker, Alfred, Gao, Xiaoyu, Bebu, Ionut, Nelson, Robert G., Molitch, Mark, Batlle, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788980/
https://www.ncbi.nlm.nih.gov/pubmed/31605461
http://dx.doi.org/10.14814/phy2.14242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788980/
https://www.ncbi.nlm.nih.gov/pubmed/31605461
http://dx.doi.org/10.14814/phy2.14242

Ejemplares similares